Delivery Order SPE2DB20D1100-SPE2DB24FA2H5

Award Date 2/13/24
Potential Completion Date 2/14/24
Potential Value $2.8K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $6,046.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. This delivery order has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to provide pharmaceutical products and medical supplies to DLA...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, in the amount of $7,327.60 to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML. The delivery order has a completion date of February 23, 2024 and was awarded on February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract and there is no set-aside designation. Additionally, Amerisourcebergen Drug Corp holds an indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order valued at $2,530.62 to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of medical commodities in support of military treatment programs and...
The Defense Logistics Agency (DLA) has awarded a $5,431.64 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as Amerisourcebergen's primary contract vehicle for delivering...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the for-profit pharmaceutical distribution company AmerisourceBergen Corporation. The $7,213.29 award is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a specialty pharmaceutical product. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through December 31, 2025, which serves as the...
The Defense Logistics Agency (DLA) awarded a $17,973.50 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML pharmaceutical products. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order worth $1,741.62 by the Defense Logistics Agency (DLA) to provide OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, with a completion date of February 16, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen Drug Corp and DLA, which serves as the primary contract vehicle for...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the procurement of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML pharmaceutical products. The delivery order has a potential value of $1,523.86 and a completion date of March 6, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that provides a wide range of pharmaceutical products and medical supplies to U.S....
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is valued at $11,533.00 and has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp will provide the DLA with the pharmaceutical product OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML. This delivery order is part of a larger indefinite delivery contract...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $5,805.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a pharmaceutical product, with a completion date of January 31, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that provides a wide range of pharmaceutical products and medical...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA2H5
    Delivery Order

The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $2,793.62 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. This delivery order is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a specialty pharmaceutical product, with a performance period ending on February 14, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this contract, which is not designated as a set-aside. Additionally, Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide.

Generated 5/14/24, 11:41 AM